Boston Sci, Medtronic respond to HRS guidance
This article was originally published in The Gray Sheet
Executive Summary
Hours after the Heart Rhythm Society released draft recommendations on the postmarket surveillance of ICDs and pacemakers on April 26, new market entrant Boston Scientific reported plans to implement all of the suggestions contained in the report. The firm recently acquired Guidant, which announced a string of cardiac rhythm management recalls last year, sparking HRS and other stakeholders to enhance their focus on issues of product safety monitoring and communication. ICD manufacturer Medtronic also expressed its support for a number of the guidelines, noting that several of the recommendations have been "Medtronic standard practice for years"...